Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ten-day decitabine vs "3+7" in patients with AML aged ≥60 years: long-term results of the randomized phase 3 EORTC trial AML21.

Blood neoplasia·2026
Same author

Stress unmasks impaired endocrine coordination of glucose metabolism in dystrophin deficiency.

bioRxiv : the preprint server for biology·2026
Same author

Regimen-dependent glucocorticoid effects improve muscle performance without altering CNS physiology in mdx mice.

The Journal of physiology·2026
Same author

Transcription-based identification of uncharacterized genes in the human immune response.

European journal of human genetics : EJHG·2026
Same author

In-depth analysis of osmotic gradient ektacytometry parameters across different genotypes in hereditary spherocytosis.

British journal of haematology·2026
Same author

NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis.

Blood·2025

Related Experiment Video

Updated: May 29, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Microarray-based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia.

Annet Simons1, Marian Stevens-Kroef, Najat El Idrissi-Zaynoun

  • 1Department of Human Genetics, Radboud University Nijmegen Medical Centre, Radboud University Centre for Oncology, Nijmegen, The Netherlands. a.simons@antrg.umcn.nl

Genes, Chromosomes & Cancer
|September 2, 2011
PubMed
Summary

Microarray genomic profiling significantly improves the detection of copy number aberrations (CNAs) in acute lymphoblastic leukemia (ALL), surpassing conventional karyotyping in sensitivity and specificity for genetic diagnosis.

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Related Experiment Videos

Last Updated: May 29, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Area of Science:

  • Genomics
  • Oncology
  • Clinical Diagnostics

Background:

  • Genomic abnormalities are crucial for acute lymphoblastic leukemia (ALL) diagnosis and prognosis.
  • Conventional karyotyping and FISH are standard but have limitations in resolution and yield.
  • Accurate genetic profiling is essential for effective ALL management.

Purpose of the Study:

  • To evaluate microarray-based genomic profiling as a feasible alternative to conventional methods for ALL genetic diagnosis.
  • To compare the diagnostic yield of microarray analysis versus karyotyping in ALL cases.
  • To establish a workflow for routine clinical application of microarray profiling in ALL.

Main Methods:

  • Compared microarray-deduced copy number aberration (CNA) karyotypes with conventional karyotypes in 60 ALL cases.
  • Assessed the detection rate and characteristics of genetic lesions using both methods.
  • Developed a practical workflow for CNA interpretation from microarray data.

Main Results:

  • Microarray profiling achieved a 90% CNA detection rate, compared to 61% for conventional karyotyping.
  • Identified numerous small (< 5 Mb) genetic lesions, including those affecting key ALL-related genes (e.g., CDKN2A/B, ETV6, PAX5, IKZF1).
  • Microarray demonstrated higher sensitivity and specificity in detecting CNAs relevant to ALL.

Conclusions:

  • Microarray-based genomic profiling is a robust and superior tool for genetic diagnosis in ALL.
  • This method enhances the detection of clinically significant genomic aberrations compared to conventional karyotyping.
  • A proposed workflow facilitates the routine clinical implementation of microarray profiling for ALL genetic diagnostics.